Evidence map›Paper›PMID 41919004›Full record

ReviewEuropean journal of anaesthesiology and intensive care2026

Hypoglycaemia in a patient with undiagnosed Doege-Potter syndrome: A case report and narrative literature review.

Aman Vora, Simon Buelens, Chantal Mathieu, Marc Van de Velde, Dirk Van Raemdonck, Steffen Rex, Layth Al Tmimi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in European journal of anaesthesiology and intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aman VoraFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Simon BuelensFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Chantal MathieuFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Marc Van de VeldeFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Dirk Van RaemdonckFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Steffen RexFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).
Layth Al TmimiFrom the Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium (AV, MVDV, SR, LA), Département medico-chirurgical de cardiologie congénital, fœtale, pédiatrique et adulte, Hôpital Louis Pradel, Bron, France (SB), Department of Medicine and Division of Endocrinology, University Hospitals Leuven (CM), Department of Clinical and Experimental Endocrinology, KU Leuven (CM), Department of Thoracic Surgery, University Hospitals Leuven (DVR), Department of Chronic Diseases and Metabolism (DVR) and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (MVDV, SR, LA).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doege-Potter syndrome (DPS) is a rare paraneoplastic disorder characterised by non-islet cell tumour hypoglycaemia (NICTH), resulting from ectopic secretion of insulin-like growth factor 2 (IGF-II) by solitary fibrous tumours (SFTs). We describe the case of an 85-year-old woman, presenting in October 2024, with a chronic subdural haematoma and profound intraoperative hypoglycaemia. Further investigation revealed a large pleural mass; the pathophysiological findings were consistent with DPS, and histopathology confirmed a malignant SFT. Hypoglycaemia resolved after complete tumour resection. The current case highlights the importance of considering NICTH in older patients with unexplained, treatment-resistant hypoglycaemia, especially when comorbidities (like subdural hematoma) mask the clinical picture. A focused narrative review accompanies this report, providing clinicians with practical insights into the spectrum of clinical presentations, diagnostic work-up, therapeutic modalities, and anaesthetic considerations in DPS. Early recognition is crucial to avoid serious complications. Complete surgical removal remains the cornerstone of effective management, while alternative therapies may be needed in inoperable cases.

Identifiers

PMID41919004
PMCPMC13034917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.